-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Analyzing CardioGenics (OTCMKTS:CGNH) and QuinStreet (NASDAQ:QNST)
Analyzing CardioGenics (OTCMKTS:CGNH) and QuinStreet (NASDAQ:QNST)
CardioGenics (OTCMKTS:CGNH – Get Rating) and QuinStreet (NASDAQ:QNST – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, valuation and analyst recommendations.
Analyst Ratings
This is a breakdown of recent ratings for CardioGenics and QuinStreet, as reported by MarketBeat.
Get CardioGenics alerts:Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
CardioGenics | 0 | 0 | 0 | 0 | N/A |
QuinStreet | 0 | 1 | 2 | 0 | 2.67 |
QuinStreet has a consensus price target of $13.50, indicating a potential upside of 9.31%.
Institutional and Insider Ownership
91.0% of QuinStreet shares are owned by institutional investors. 41.4% of CardioGenics shares are owned by company insiders. Comparatively, 6.8% of QuinStreet shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.Volatility and Risk
CardioGenics has a beta of 0.52, meaning that its stock price is 48% less volatile than the S&P 500. Comparatively, QuinStreet has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500.
Profitability
This table compares CardioGenics and QuinStreet's net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
CardioGenics | N/A | N/A | N/A |
QuinStreet | -0.90% | -1.77% | -1.22% |
Valuation & Earnings
This table compares CardioGenics and QuinStreet's revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
CardioGenics | N/A | N/A | N/A | N/A | N/A |
QuinStreet | $582.10 million | 1.16 | -$5.25 million | ($0.09) | -137.21 |
CardioGenics has higher earnings, but lower revenue than QuinStreet.
About CardioGenics
(Get Rating)
CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.
About QuinStreet
(Get Rating)
QuinStreet, Inc., an online performance marketing company, provides customer acquisition services for its clients in the United States and internationally. The company offers online marketing services to its clients in the form of qualified clicks, leads, calls, applications, or customers through its websites or third-party publishers. It provides its services in various verticals, such as financial services and home services. The company was incorporated in 1999 and is headquartered in Foster City, California.
Receive News & Ratings for CardioGenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CardioGenics and related companies with MarketBeat.com's FREE daily email newsletter.
CardioGenics (OTCMKTS:CGNH – Get Rating) and QuinStreet (NASDAQ:QNST – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, valuation and analyst recommendations.
心臟基因公司(OTCMKTS:CGNH-GET Rating)和QuinStreet(納斯達克:QNST-GET Rating)都是小盤股醫療公司,但哪種投資更好?我們將根據兩家公司的風險、機構所有權、盈利能力、收益、股息、估值和分析師建議來比較它們的實力。
Analyst Ratings
分析師評級
This is a breakdown of recent ratings for CardioGenics and QuinStreet, as reported by MarketBeat.
這是據MarketBeat報道的心臟基因公司和QuinStreet最近的評級細目。
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
CardioGenics | 0 | 0 | 0 | 0 | N/A |
QuinStreet | 0 | 1 | 2 | 0 | 2.67 |
銷售評級 | 保持評級 | 購買評級 | 強勁的買入評級 | 評級分數 | |
心臟基因組學 | 0 | 0 | 0 | 0 | 不適用 |
昆斯街 | 0 | 1 | 2 | 0 | 2.67 |
QuinStreet has a consensus price target of $13.50, indicating a potential upside of 9.31%.
QuinStreet的普遍目標價為13.50美元,表明潛在上行空間為9.31%。
Institutional and Insider Ownership
機構和內部人持股
Volatility and Risk
波動性和風險
CardioGenics has a beta of 0.52, meaning that its stock price is 48% less volatile than the S&P 500. Comparatively, QuinStreet has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500.
心臟基因公司的貝塔指數為0.52,這意味着其股價的波動性比標準普爾500指數低48%。相比之下,QuinStreet的貝塔係數為1.02,這意味着其股價的波動性比標準普爾500指數高2%。
Profitability
盈利能力
This table compares CardioGenics and QuinStreet's net margins, return on equity and return on assets.
此表比較了心臟基因公司和昆斯特里特公司的淨利潤率、股本回報率和資產回報率。
Net Margins | Return on Equity | Return on Assets | |
CardioGenics | N/A | N/A | N/A |
QuinStreet | -0.90% | -1.77% | -1.22% |
淨利潤率 | 股本回報率 | 資產回報率 | |
心臟基因組學 | 不適用 | 不適用 | 不適用 |
昆斯街 | -0.90% | -1.77% | -1.22% |
Valuation & Earnings
估值與收益
This table compares CardioGenics and QuinStreet's revenue, earnings per share (EPS) and valuation.
此表比較了心臟基因公司和QuinStreet公司的收入、每股收益(EPS)和估值。
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
CardioGenics | N/A | N/A | N/A | N/A | N/A |
QuinStreet | $582.10 million | 1.16 | -$5.25 million | ($0.09) | -137.21 |
總收入 | 價格/銷售額比 | 淨收入 | 每股收益 | 市盈率 | |
心臟基因組學 | 不適用 | 不適用 | 不適用 | 不適用 | 不適用 |
昆斯街 | 5.821億美元 | 1.16 | -525萬元 | ($0.09) | -137.21 |
CardioGenics has higher earnings, but lower revenue than QuinStreet.
心臟基因公司的收入比QuinStreet更高,但收入更低。
About CardioGenics
關於心臟基因組學
(Get Rating)
(獲取評級)
CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.
心臟基因控股公司致力於為美國、加拿大、歐洲和國際上的體外診斷測試市場開發診斷測試產品並將其商業化。該公司的產品包括QL Care Analyzer,這是一款便攜式、獨立和自動化的護理點(POC)免疫分析分析儀,它使用專有的自計量盒在POC進行免疫分析測試;一系列免疫分析測試,以識別心臟病發作時血液中的心臟標誌物;以及順磁珠,在臨牀和研究實驗室的異類免疫分析測試中用作固體表面。該公司前身為Jag Media Holdings,Inc.,並於2009年更名為心臟基因控股公司。該公司成立於1997年,總部設在加拿大密西索加。
About QuinStreet
關於QuinStreet
(Get Rating)
(獲取評級)
QuinStreet, Inc., an online performance marketing company, provides customer acquisition services for its clients in the United States and internationally. The company offers online marketing services to its clients in the form of qualified clicks, leads, calls, applications, or customers through its websites or third-party publishers. It provides its services in various verticals, such as financial services and home services. The company was incorporated in 1999 and is headquartered in Foster City, California.
QuinStreet,Inc.是一家在線績效營銷公司,為其在美國和國際上的客户提供客户獲取服務。該公司通過其網站或第三方出版商,以合格點擊、線索、電話、應用或客户的形式向客户提供在線營銷服務。它在各種垂直領域提供服務,如金融服務和家居服務。該公司成立於1999年,總部設在加利福尼亞州福斯特城。
Receive News & Ratings for CardioGenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CardioGenics and related companies with MarketBeat.com's FREE daily email newsletter.
接受《心臟基因組日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊,接收最新新聞和分析師對心臟基因公司和相關公司評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧